BioNexus Gene Lab Corp
NASDAQ:BGLC
Shareholder Yield
Current shareholder yield for 
BGLC is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BGLC Price
BioNexus Gene Lab Corp
| Average Annual Return | -43.49% |
| Standard Deviation of Annual Returns | 39.41% |
| Max Drawdown | -99% |
| Market Capitalization | 3.5m USD |
| Shares Outstanding | 1 800 000 |
| Percentage of Shares Shorted | 0.86% |
BGLC Return Decomposition
Main factors of price return
Stock Splits
BGLC's latest stock split occurred on Apr 7, 2025
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, BGLC traded at 0.235 per share. Afterward, the share price was about 2.92.
The adjusted shares began trading on Apr 7, 2025. This was BGLC's 2nd stock split, following the previous one in Jul 20, 2023.
